Inhaler with aperatured porous support element

1. An inhaler article comprising:

a body extending along a longitudinal axis from a mouthpiece end to a distal end;

an endpiece element at the distal end;

a capsule cavity defined within the body and extending along the longitudinal axis a cavity length;

an air inlet region between the endpiece element and the capsule cavity, the air inlet region having an air inlet and an air passageway defining a vortex tunnel extending from the air inlet to the capsule cavity, the air passageway comprising an inner diameter less than an inner diameter of the capsule cavity, the vortex tunnel extending longitudinally along the longitudinal axis of the inhaler article body;

a porous support element defining a downstream end of the capsule cavity, the porous support element formed of a porous material, the porous support element extending along a longitudinal axis a length, the porous support element comprises one or more apertures extending the length of the porous support element;

a mouthpiece air channel extending from the capsule cavity, through the porous support element to the mouthpiece end,

wherein the one or more apertures of the porous support element form helical features along the length of the porous support element.

2. The inhaler article according to claim 1 , wherein the porous support element is formed of a polylactic acid material or cellulose acetate material.

3. The inhaler article according claim 1 , wherein the porous support element comprises two apertures, or three apertures, or four apertures, or five apertures, or six apertures, or seven apertures.

4. The inhaler article according claim 1 , wherein the porous support element comprises the two or more apertures along an outer diameter of the porous support element.

5. The inhaler article according claim 1 , wherein the porous support element has a centre region co-incident with the longitudinal axis and the centre region includes an aperture.

6. The inhaler article according to claim 1 , wherein the porous support element has a centre region co-incident with the longitudinal axis and the centre region does not include an aperture.

7. The inhaler article according to claim 1 , wherein the porous support element has a centre region co-incident with the longitudinal axis and the centre region includes an aperture and four or more apertures along an outer diameter of the porous support element.

8. The inhaler article according to claim 3 , wherein the apertures are equally spaced from each other along an outer diameter of the porous support element.

9. The inhaler article according to claim 1 , wherein the one or more apertures define at least about 40% of a circular cross-sectional surface area of the porous support element.

10. The inhaler article according to claim 1 , wherein the vortex tunnel induces a vortex of inhalation airflow into the capsule cavity.

11. The inhaler article according to claim 1 , wherein the inner diameter of the air passageway is about 2 mm to about 4.5 mm and is less than an inner diameter of the capsule cavity.

12. The inhaler article according to claim 10 , wherein the vortex tunnel comprises a length that is greater than the inner diameter of the vortex tunnel.

13. The inhaler article according to claim 12 , wherein the inner diameter of the vortex tunnel is about 2 mm to about 4.5 mm that is less than an inner diameter of the capsule cavity.

14. The inhaler article according to claim 1 , wherein the one or more apertures define a range from about 15% to about 60% of a circular cross-sectional surface area of the porous support element.

15. An inhaler system comprising, the inhaler article according to claim 1 , and a capsule disposed within the capsule cavity of the inhaler article, the capsule containing pharmaceutically active particles, the pharmaceutically active particles having a mass median aerodynamic diameter in a range from about 0.5 micrometres to about 4 micrometres.

16. The system according to claim 15 , wherein the capsule contains pharmaceutically active particles comprising nicotine.

17. The system according to claim 16 , wherein the capsule further contains a second population of flavour particles having a mass median aerodynamic diameter in a range from about 50 to about 200 micrometres.

18. The system according to claim 15 , wherein the system further comprises a piercing element removably engageable with the inhaler article to activate the capsule and wherein the endpiece element is configured to be pierced by the piercing element when activating the capsule.